With Heavy Alcohol Use Increasing, Evernorth Expands Access To Treatment with Monument’s Virtual Services
Through the Evernorth Behavioral Health Network, customers can now use Monument’s online peer support, personalized therapy, and provider-prescribed medication to help them achieve sobriety or moderat...
Read MoreHow Value-based Solutions Can Improve Costs and Health Outcomes for Chronic Conditions
Over 125 million Americans suffer from chronic conditions, costing the U.S. over $3.4 trillion annually. This topic was the focus of a breakout session at Outcomes+ 2022.
Read MoreEvernorth and Behavioral Health Center of Excellence Collaborate to Measure Health Outcomes for Autism Treatment
First-of-its-kind partnership will establish quality performance metrics to drive improvements in quality of therapy for autism spectrum disorder
Read MoreEvernorth and Kaiser Permanente Enter Strategic Collaboration to Deliver More Convenient, Affordable and Accessible Health Care
Broad agreement aims to increase convenience and expand affordable access to valuable health benefits and high-quality care to millions more Americans Kaiser Permanente members will benefit from ac...
Read MoreWhat Is Drug Trend and How to Manage it
Drug trend, a good annual barometer for plan sponsor who are looking to control traditional and specialty drug costs, can and should be managed to improve medication access. This topic was the foc...
Read MoreUnderserved Communities at Greater Risk for Non-adherence to Diabetes Medication
Evernorth Geographic Social Determinants Index (EGSDI) identifies opportunities for proactive patient and community engagement for individuals diagnosed with type 2 diabetes.
Read MoreNurses Improve Health Outcomes
Whether nurses have direct interaction with patients or work in non-traditional roles, their knowledge and expertise can improve health outcomes for patients.
Read MoreReducing the Unexpected and Unnecessary Costs of Musculoskeletal Condition Care
Musculoskeletal (MSK) injuries or disorders affect nearly half of U.S. adults1 and are one of the top health categories of plan sponsor spend at $420B. This topic was the focus of a breakout sessi...
Read MoreBiosimilar Approval and Adoption Challenges
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Read More